{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:57:28Z","timestamp":1788325048406,"version":"build-2803163510"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fentanyl, an opioid medication commonly given to hospitalized preterm infants, may alter gut microbiome development and subsequent neurodevelopmental outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We compare a cohort of preterm infants with and without postnatal fentanyl exposure, using their hospitalization stool samples and neurodevelopmental outcomes. The study examines the association between fentanyl exposure, fecal microbiome differences during NICU stay, and neurodevelopmental outcomes up to age 8.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fentanyl exposure during NICU hospitalization is associated with a decrease in fecal microbiome richness, negative association with the microbial taxa\n                      <jats:italic>Actinobacteriota<\/jats:italic>\n                      and\n                      <jats:italic>Bacteroidia<\/jats:italic>\n                      , increase in constipation, an increase of microbiome derived metabolites involved in inflammation and gastrointestinal (GI) homeostasis, and altered microbial virulence (i.e. factors that contribute to pathogenicity). Increased fentanyl exposure is associated with worse cognitive scores on the Bayley Scales of Infant and Toddler Development at 2 years of age and the intelligence quotient composite score on the Wechsler Preschool and Primary Scale of Intelligence at 3\u20138 years of age. Virulence factors present in the microbiome mediated the association between fentanyl and cognitive outcomes at 2 years old.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Increased duration of postnatal fentanyl exposure in preterm infants is associated with gut microbiome differences (i.e. richness and virulence) and later cognitive impairment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Impact<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Postnatal fentanyl exposure of premature infants in the neonatal intensive care unit is associated with microbiome differences that manifest during their hospital stay.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Fentanyl-associated microbiome differences during hospitalization include differences in fecal richness, microbial taxa composition, gastrointestinal transit time, microbiome-derived metabolites, and microbial virulence.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Early gut fentanyl-associated microbiota differences are associated with worse cognitive outcomes in preterm infants at 2\u20138 years old.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41390-026-05210-1","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:47:10Z","timestamp":1782215230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Associations between fentanyl exposure, gut microbiome and neurodevelopmental outcomes in preterm infants"],"prefix":"10.1038","author":[{"given":"Pyone","family":"David","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Oliphant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bree","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Byrne-Bowens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anson","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfredo","family":"Cruz Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinanath","family":"Sulakhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika C.","family":"Claud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"5210_CR1","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.clp.2014.08.010","volume":"41","author":"RW Hall","year":"2014","unstructured":"Hall, R. W. & Anand, K. J. Pain management in newborns. Clin. Perinatol. 41, 895\u2013924 (2014).","journal-title":"Clin. Perinatol."},{"key":"5210_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00875-0","volume":"8","author":"G Berg","year":"2020","unstructured":"Berg, G. et al. Microbiome definition re-visited: old concepts and new challenges. Microbiome 8, 103 (2020).","journal-title":"Microbiome"},{"key":"5210_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/SLA.0b013e3182331870","volume":"255","author":"T Babrowski","year":"2012","unstructured":"Babrowski, T. et al. Pseudomonas aeruginosa virulence expression is directly activated by morphine and is capable of causing lethal gut-derived sepsis in mice during chronic morphine administration. Ann. Surg. 255, 386\u2013393 (2012).","journal-title":"Ann. Surg."},{"key":"5210_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-3-031-58572-2_2","volume":"1449","author":"P David","year":"2024","unstructured":"David, P. & Claud, E. C. Necrotizing enterocolitis and the preterm infant microbiome. Adv. Exp. Med. Biol. 1449, 29\u201341 (2024).","journal-title":"Adv. Exp. Med. Biol."},{"key":"5210_CR5","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.alit.2017.07.010","volume":"66","author":"M Tanaka","year":"2017","unstructured":"Tanaka, M. & Nakayama, J. Development of the gut microbiota in infancy and its impact on health in later life. Allergol. Int. 66, 515\u2013522 (2017).","journal-title":"Allergol. Int."},{"key":"5210_CR6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.bja.2019.07.026","volume":"123","author":"R Guo","year":"2019","unstructured":"Guo, R., Chen, L. H., Xing, C. & Liu, T. Pain regulation by gut microbiota: molecular mechanisms and therapeutic potential. Br. J. Anaesth. 123, 637\u2013654 (2019).","journal-title":"Br. J. Anaesth."},{"key":"5210_CR7","doi-asserted-by":"crossref","unstructured":"Antoine, D., Singh, P. K., Tao, J. & Roy, S. Neonatal morphine results in long-lasting alterations to the gut microbiome in adolescence and adulthood in a murine model. Pharmaceutics 14, 1879 (2022).","DOI":"10.3390\/pharmaceutics14091879"},{"key":"5210_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41564-021-01025-4","volume":"7","author":"DB Healy","year":"2022","unstructured":"Healy, D. B., Ryan, C. A., Ross, R. P., Stanton, C. & Dempsey, E. M. Clinical implications of preterm infant gut microbiome development. Nat. Microbiol. 7, 22\u201333 (2022).","journal-title":"Nat. Microbiol."},{"key":"5210_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01170-x","volume":"21","author":"B Lin","year":"2020","unstructured":"Lin, B. et al. Gut microbiota regulates neuropathic pain: potential mechanisms and therapeutic strategy. J. Headache Pain. 21, 103 (2020).","journal-title":"J. Headache Pain."},{"key":"5210_CR10","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1073\/pnas.0711891105","volume":"105","author":"FA Amaral","year":"2008","unstructured":"Amaral, F. A. et al. Commensal microbiota is fundamental for the development of inflammatory pain. Proc. Natl. Acad. Sci. USA 105, 2193\u20132197 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"5210_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1203\/PDR.0b013e3181c8eef3","volume":"67","author":"X Durrmeyer","year":"2010","unstructured":"Durrmeyer, X., Vutskits, L., Anand, K. J. & Rimensberger, P. C. Use of analgesic and sedative drugs in the NICU: integrating clinical trials and laboratory data. Pediatr. Res. 67, 117\u2013127 (2010).","journal-title":"Pediatr. Res"},{"key":"5210_CR12","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.1542\/neo.25-6-e325","volume":"25","author":"J Fong","year":"2024","unstructured":"Fong, J., Lewis, J., Lam, M. & Kesavan, K. Developmental outcomes after opioid exposure in the fetus and neonate. Neoreviews 25, e325\u2013e337 (2024).","journal-title":"Neoreviews"},{"key":"5210_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntt.2021.107002","volume":"86","author":"B Velasco","year":"2021","unstructured":"Velasco, B., Mohamed, E. & Sato-Bigbee, C. Endogenous and exogenous opioid effects on oligodendrocyte biology and developmental brain myelination. Neurotoxicol. Teratol. 86, 107002 (2021).","journal-title":"Neurotoxicol. Teratol."},{"key":"5210_CR14","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1177\/1060028015606732","volume":"49","author":"C McPherson","year":"2015","unstructured":"McPherson, C. et al. Brain injury and development in preterm infants exposed to fentanyl. Ann. Pharmacother. 49, 1291\u20131297 (2015).","journal-title":"Ann. Pharmacother."},{"key":"5210_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2022.836705","volume":"3","author":"KP Mills","year":"2022","unstructured":"Mills, K. P. et al. Fentanyl exposure in preterm infants: five-year neurodevelopmental and socioemotional assessment. Front Pain. Res. (Lausanne) 3, 836705 (2022).","journal-title":"Front Pain. Res. (Lausanne)"},{"key":"5210_CR16","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1177\/0883073809338067","volume":"24","author":"JJ Volpe","year":"2009","unstructured":"Volpe, J. J. Cerebellum of the premature infant: rapidly developing, vulnerable, clinically important. J. Child Neurol. 24, 1085\u20131104 (2009).","journal-title":"J. Child Neurol."},{"key":"5210_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12311-014-0597-9","volume":"14","author":"M Brossard-Racine","year":"2015","unstructured":"Brossard-Racine, M., du Plessis, A. J. & Limperopoulos, C. Developmental cerebellar cognitive affective syndrome in ex-preterm survivors following cerebellar injury. Cerebellum 14, 151\u2013164 (2015).","journal-title":"Cerebellum"},{"key":"5210_CR18","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.1523\/JNEUROSCI.2083-21.2022","volume":"42","author":"JB Alipio","year":"2022","unstructured":"Alipio, J. B., Riggs, L. M., Plank, M. & Keller, A. Environmental enrichment mitigates the long-lasting sequelae of perinatal fentanyl exposure in mice. J. Neurosci. 42, 3557\u20133569 (2022).","journal-title":"J. Neurosci."},{"key":"5210_CR19","doi-asserted-by":"crossref","unstructured":"Oliphant, K. et al. Bacteroidota and Lachnospiraceae integration into the gut microbiome at key time points in early life are linked to infant neurodevelopment. Gut Microbes 13, 1997560 (2021).","DOI":"10.1080\/19490976.2021.1997560"},{"key":"5210_CR20","doi-asserted-by":"crossref","unstructured":"Nancy, B. Bayley Scales of Infant and Toddler Development 3rd edn (The Psychological Corporation, 2006).","DOI":"10.1037\/t14978-000"},{"key":"5210_CR21","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/pr.2014.10","volume":"75","author":"S Johnson","year":"2014","unstructured":"Johnson, S., Moore, T. & Marlow, N. Using the Bayley-III to assess neurodevelopmental delay: which cut-off should be used? Pediatr. Res. 75, 670\u2013674 (2014).","journal-title":"Pediatr. Res"},{"key":"5210_CR22","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/DBP.0000000000000110","volume":"35","author":"MM Bode","year":"2014","unstructured":"Bode, M. M., D\u02bcEugenio, D. B., Mettelman, B. B. & Gross, S. J. Predictive validity of the Bayley, Third Edition at 2 years for intelligence quotient at 4 years in preterm infants. J. Dev. Behav. Pediatr. 35, 570\u2013575 (2014).","journal-title":"J. Dev. Behav. Pediatr."},{"key":"5210_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/0734282913508620","volume":"32","author":"M Syeda","year":"2014","unstructured":"Syeda, M. & Climie, E. Test Review: wechsler preschool and primary scale of intelligence\u2014fourth edition. J. Psychoeduc. Assess. 32, 265\u2013272 (2014).","journal-title":"J. Psychoeduc. Assess."},{"key":"5210_CR24","unstructured":"Barnett, A. L. & Henderson S. E. In An Annotated Bibliography of Studies Using the TOMI\/Movement ABC: 1984\u20131996 (The Psychological Corporation, 1998)."},{"key":"5210_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0022-4405(90)90022-Y","volume":"28","author":"BA Bracken","year":"1990","unstructured":"Bracken, B. A. et al. Multinational validation of the Bracken Basic Concept Scale. J. Sch. Psychol. 28, 325\u2013341 (1990).","journal-title":"J. Sch. Psychol."},{"key":"5210_CR26","unstructured":"Harrison, P. L. & Oakland, T. In Adaptive Behavior Assessment System, 3rd edn (Western Psychological Services, Torrance, CA, 2015)."},{"key":"5210_CR27","unstructured":"Gioia, G. A., Espy, K. A. & Isquith, P. K. In Behavior Rating Inventory of Executive Function-Preschool Version (Psychological Assessment Resources, 2003)."},{"key":"5210_CR28","doi-asserted-by":"publisher","first-page":"7731","DOI":"10.3390\/ijerph19137731","volume":"19","author":"M Grasso","year":"2022","unstructured":"Grasso, M. et al. The strengths and difficulties questionnaire as a valuable screening tool for identifying core symptoms and behavioural and emotional problems in children with neuropsychiatric disorders.  Int. J. Environ. Res. Public Health 19, 7731 (2022).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"5210_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s40474-017-0122-1","volume":"4","author":"AR Marvin","year":"2017","unstructured":"Marvin, A. R., Marvin, D. J., Lipkin, P. H. & Law, J. K. Analysis of Social Communication Questionnaire (SCQ) screening for children less than age 4. Curr. Dev. Disord. Rep. 4, 137\u2013144 (2017).","journal-title":"Curr. Dev. Disord. Rep."},{"key":"5210_CR30","doi-asserted-by":"crossref","unstructured":"Walters, W. et al. Improved bacterial 16S rRNA gene (V4 and V4-5) and fungal internal transcribed spacer marker gene primers for microbial community surveys. mSystems 1, 10\u20131128 (2016).","DOI":"10.1128\/mSystems.00009-15"},{"key":"5210_CR31","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/ismej.2012.8","volume":"6","author":"JG Caporaso","year":"2012","unstructured":"Caporaso, J. G. et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 6, 1621\u20131624 (2012).","journal-title":"ISME J."},{"key":"5210_CR32","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1002\/cpbi.100","volume":"70","author":"M Estaki","year":"2020","unstructured":"Estaki, M. et al. QIIME 2 enables comprehensive end-to-end analysis of diverse microbiome data and comparative studies with publicly available data. Curr. Protoc. Bioinform. 70, e100 (2020).","journal-title":"Curr. Protoc. Bioinform."},{"key":"5210_CR33","doi-asserted-by":"publisher","first-page":"7188","DOI":"10.1093\/nar\/gkm864","volume":"35","author":"E Pruesse","year":"2007","unstructured":"Pruesse, E. et al. SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res. 35, 7188\u20137196 (2007).","journal-title":"Nucleic Acids Res"},{"key":"5210_CR34","doi-asserted-by":"crossref","unstructured":"Anderson, M. Permutational Multivariate Analysis of Variance (PERMANOVA). in Wiley StatsRef: Statistics Reference Online 1\u201315 John Wiley & Sons, Ltd; (2017).","DOI":"10.1002\/9781118445112.stat07841"},{"key":"5210_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1339422","volume":"15","author":"S Yang","year":"2024","unstructured":"Yang, S. et al. Characteristics of intestinal microbiota in preterm infants and the effects of probiotic supplementation on the microbiota. Front. Microbiol. 15, 1339422 (2024).","journal-title":"Front. Microbiol."},{"key":"5210_CR36","doi-asserted-by":"publisher","first-page":"12522","DOI":"10.1073\/pnas.1409497111","volume":"111","author":"PS La Rosa","year":"2014","unstructured":"La Rosa, P. S. et al. Patterned progression of bacterial populations in the premature infant gut. Proc. Natl. Acad. Sci. USA 111, 12522\u201312527 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"5210_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-024-10621-7","volume":"25","author":"D Bars-Cortina","year":"2024","unstructured":"Bars-Cortina, D. et al. Comparison between 16S rRNA and shotgun sequencing in colorectal cancer, advanced colorectal lesions, and healthy human gut microbiota. BMC Genom. 25, 730 (2024).","journal-title":"BMC Genom."},{"key":"5210_CR38","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41564-022-01230-9","volume":"7","author":"K Oliphant","year":"2022","unstructured":"Oliphant, K. & Claud, E. C. Early probiotics shape microbiota. Nat. Microbiol. 7, 1506\u20131507 (2022).","journal-title":"Nat. Microbiol"},{"key":"5210_CR39","doi-asserted-by":"publisher","first-page":"e54040","DOI":"10.1371\/journal.pone.0054040","volume":"8","author":"J Meng","year":"2013","unstructured":"Meng, J. et al. Morphine induces bacterial translocation in mice by compromising intestinal barrier function in a TLR-dependent manner. PLoS ONE 8, e54040 (2013).","journal-title":"PLoS ONE"},{"key":"5210_CR40","doi-asserted-by":"crossref","unstructured":"Beharry K. D. et al. Factors influencing neonatal gut microbiome and health with a focus on necrotizing enterocolitis. Microorganisms 11, 2528 (2023).","DOI":"10.3390\/microorganisms11102528"},{"key":"5210_CR41","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/j.chom.2024.07.027","volume":"32","author":"R Th\u00e4nert","year":"2024","unstructured":"Th\u00e4nert, R. et al. Clinical sequelae of gut microbiome development and disruption in hospitalized preterm infants. Cell Host Microbe 32, 1822\u20131837.e5 (2024).","journal-title":"Cell Host Microbe"},{"key":"5210_CR42","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41586-021-03241-8","volume":"591","author":"C Rao","year":"2021","unstructured":"Rao, C. et al. Multi-kingdom ecological drivers of microbiota assembly in preterm infants. Nature 591, 633\u2013638 (2021).","journal-title":"Nature"},{"key":"5210_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02018-w","volume":"8","author":"B Brooks","year":"2017","unstructured":"Brooks, B. et al. Strain-resolved analysis of hospital rooms and infants reveals overlap between the human and room microbiome. Nat. Commun. 8, 1814 (2017).","journal-title":"Nat. Commun."},{"key":"5210_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0493-5","volume":"6","author":"B Brooks","year":"2018","unstructured":"Brooks, B. et al. The developing premature infant gut microbiome is a major factor shaping the microbiome of neonatal intensive care unit rooms. Microbiome 6, 112 (2018).","journal-title":"Microbiome"},{"key":"5210_CR45","doi-asserted-by":"publisher","first-page":"16024","DOI":"10.1038\/nmicrobiol.2016.24","volume":"1","author":"MK Gibson","year":"2016","unstructured":"Gibson, M. K. et al. Developmental dynamics of the preterm infant gut microbiota and antibiotic resistome. Nat. Microbiol. 1, 16024 (2016).","journal-title":"Nat. Microbiol."},{"key":"5210_CR46","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg5562","volume":"15","author":"DJ Schwartz","year":"2023","unstructured":"Schwartz, D. J. et al. Gut pathogen colonization precedes bloodstream infection in the neonatal intensive care unit. Sci. Transl. Med. 15, eadg5562 (2023).","journal-title":"Sci. Transl. Med."},{"key":"5210_CR47","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1101\/gr.213256.116","volume":"27","author":"MR Olm","year":"2017","unstructured":"Olm, M. R. et al. Identical bacterial populations colonize premature infant gut, skin, and oral microbiomes and exhibit different in situ growth rates. Genome Res. 27, 601\u2013612 (2017).","journal-title":"Genome Res."},{"key":"5210_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/2049-2618-2-1","volume":"2","author":"B Brooks","year":"2014","unstructured":"Brooks, B. et al. Microbes in the neonatal intensive care unit resemble those found in the gut of premature infants. Microbiome 2, 1 (2014).","journal-title":"Microbiome"},{"key":"5210_CR49","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S2468-1253(18)30008-6","volume":"3","author":"AD Farmer","year":"2018","unstructured":"Farmer, A. D. et al. Pathophysiology, diagnosis, and management of opioid-induced constipation. Lancet Gastroenterol. Hepatol. 3, 203\u2013212 (2018).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"5210_CR50","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s11938-016-0112-0","volume":"14","author":"AA Lee","year":"2016","unstructured":"Lee, A. A. & Hasler, W. L. Opioids and GI motility-friend or foe? Curr. Treat. Options Gastroenterol. 14, 478\u2013494 (2016).","journal-title":"Curr. Treat. Options Gastroenterol."},{"key":"5210_CR51","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.cgh.2017.05.014","volume":"15","author":"M Camilleri","year":"2017","unstructured":"Camilleri, M., Lembo, A. & Katzka, D. A. Opioids in gastroenterology: treating adverse effects and creating therapeutic benefits. Clin. Gastroenterol. Hepatol. 15, 1338\u20131349 (2017).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"5210_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-022-04930-6","volume":"22","author":"T Huang","year":"2022","unstructured":"Huang, T. et al. Effect of breast milk with or without bacteria on infant gut microbiota. BMC Pregnancy Childbirth 22, 595 (2022).","journal-title":"BMC Pregnancy Childbirth"},{"key":"5210_CR53","doi-asserted-by":"crossref","unstructured":"Rinninella, E. et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms 7, 14 (2019).","DOI":"10.3390\/microorganisms7010014"},{"key":"5210_CR54","unstructured":"Peterson, J. W. Bacterial pathogenesis. in Medical Microbiology 4th edn (ed. Baron, S.) Ch. 4 (University of Texas Medical Branch at Galveston, 1996)."},{"key":"5210_CR55","doi-asserted-by":"publisher","first-page":"s9","DOI":"10.1191\/0269216306pm1124oa","volume":"20","author":"P Sacerdote","year":"2006","unstructured":"Sacerdote, P. Opioids and the immune system. Palliat. Med. 20, s9\u2013s15 (2006).","journal-title":"Palliat. Med."},{"key":"5210_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-022-01419-4","volume":"10","author":"EJ Raineri","year":"2022","unstructured":"Raineri, E. J. et al. Staphylococcus aureus populations from the gut and the blood are not distinguished by virulence traits-a critical role of host barrier integrity. Microbiome 10, 239 (2022).","journal-title":"Microbiome"},{"key":"5210_CR57","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1172\/JCI18535","volume":"111","author":"FD Lowy","year":"2003","unstructured":"Lowy, F. D. Antimicrobial resistance: the example of Staphylococcus aureus. J. Clin. Invest. 111, 1265\u20131273 (2003).","journal-title":"J. Clin. Invest."},{"key":"5210_CR58","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/21505594.2021.1878688","volume":"12","author":"GYC Cheung","year":"2021","unstructured":"Cheung, G. Y. C., Bae, J. S. & Otto, M. Pathogenicity and virulence of Staphylococcus aureus. Virulence 12, 547\u2013569 (2021).","journal-title":"Virulence"},{"key":"5210_CR59","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.jpeds.2012.11.089","volume":"162","author":"NS Boghossian","year":"2013","unstructured":"Boghossian, N. S. et al. Late-onset sepsis in very low birth weight infants from singleton and multiple-gestation births. J. Pediatr. 162, 1120\u20131124.e1 (2013).","journal-title":"J. Pediatr."},{"key":"5210_CR60","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1086\/675836","volume":"35","author":"E Verstraete","year":"2014","unstructured":"Verstraete, E. et al. Healthcare-associated bloodstream infections in a neonatal intensive care unit over a 20-year period (1992-2011): trends in incidence, pathogens, and mortality. Infect. Control Hosp. Epidemiol. 35, 511\u2013518 (2014).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"5210_CR61","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1001\/jama.292.19.2357","volume":"292","author":"BJ Stoll","year":"2004","unstructured":"Stoll, B. J. et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 292, 2357\u20132365 (2004).","journal-title":"JAMA"},{"key":"5210_CR62","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1086\/649797","volume":"31","author":"X Song","year":"2010","unstructured":"Song, X., Perencevich, E., Campos, J., Short, B. L. & Singh, N. Clinical and economic impact of methicillin-resistant Staphylococcus aureus colonization or infection on neonates in intensive care units. Infect. Control Hosp. Epidemiol. 31, 177\u2013182 (2010).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"5210_CR63","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1128\/IAI.00914-09","volume":"78","author":"J Ma","year":"2010","unstructured":"Ma, J. et al. Morphine disrupts interleukin-23 (IL-23)\/IL-17-mediated pulmonary mucosal host defense against Streptococcus pneumoniae infection. Infect. Immun. 78, 830\u2013837 (2010).","journal-title":"Infect. Immun."},{"key":"5210_CR64","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.amjsurg.2006.01.001","volume":"192","author":"MG Schwacha","year":"2006","unstructured":"Schwacha, M. G. et al. The contribution of opiate analgesics to the development of infectious complications in burn patients. Am. J. Surg. 192, 82\u201386 (2006).","journal-title":"Am. J. Surg."},{"key":"5210_CR65","doi-asserted-by":"publisher","first-page":"e78822","DOI":"10.1371\/journal.pone.0078822","volume":"8","author":"AM Moore","year":"2013","unstructured":"Moore, A. M. et al. Pediatric fecal microbiota harbor diverse and novel antibiotic resistance genes. PLoS ONE 8, e78822 (2013).","journal-title":"PLoS ONE"},{"key":"5210_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41385-018-0053-0","volume":"12","author":"MT Sorbara","year":"2019","unstructured":"Sorbara, M. T. & Pamer, E. G. Interbacterial mechanisms of colonization resistance and the strategies pathogens use to overcome them. Mucosal Immunol. 12, 1\u20139 (2019).","journal-title":"Mucosal Immunol."},{"key":"5210_CR67","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.ajic.2023.10.001","volume":"52","author":"P Radhakrishnan","year":"2024","unstructured":"Radhakrishnan, P., Monteiro, J. F. G., Dombrovsky, D. & D\u2019Agata, E. M. C. Opioid exposure as a potential risk factor for vancomycin-resistant enterococci colonization in the absence of antimicrobial exposure. Am. J. Infect. Control 52, 468\u2013471 (2024).","journal-title":"Am. J. Infect. Control"},{"key":"5210_CR68","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2157-7048.1000326","volume":"8","author":"K Athankar","year":"2017","unstructured":"Athankar, K., Wasewar, K., Varma, M. & Shende, D. Recovery of glutaric acid using tri-n-butyl phosphate: effect of diluents and temperature. J. Chem. Eng. Process Technol. 8, 2 (2017).","journal-title":"J. Chem. Eng. Process Technol."},{"key":"5210_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1016872","volume":"14","author":"S Cai","year":"2023","unstructured":"Cai, S. et al. Alterations in intestinal microbiota and metabolites in individuals with Down syndrome and their correlation with inflammation and behavior disorders in mice. Front. Microbiol. 14, 1016872 (2023).","journal-title":"Front. Microbiol."},{"key":"5210_CR70","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41390-019-0740-x","volume":"88","author":"D Meng","year":"2020","unstructured":"Meng, D. et al. Indole-3-lactic acid, a metabolite of tryptophan, secreted by Bifidobacterium longum subspecies infantis is anti-inflammatory in the immature intestine. Pediatr. Res. 88, 209\u2013217 (2020).","journal-title":"Pediatr. Res."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05210-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05210-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05210-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:02:18Z","timestamp":1788285738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05210-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":70,"alternative-id":["5210"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-05210-1","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.C. has served as a consultant to legal firms and to Mead Johnson Nutrition. B.A. is an equity partner in Preeme+You, a B Corporation to improve health equity in the neonatal intensive care unit via parent engagement.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Written informed consent was obtained from the patients\u2019 legal guardians prior to their participation.","order":2,"name":"Ethics","label":"Consent statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}